Confirmed speakers
- Daniela ANGST, Novartis
- Ori AVINOAM, The Weizmann Institute of Science
- Stephan BACHMANN, Roche
- Ariel BENSIMON, Solgate GmbH
- Ewen BODIO, Université Bourgogne Franche-Comté
- Andrea BRANCALE, UCT Prague
- Mirko BUCHHOLZ, PerioTrap Pharmaceuticals
- Silvia CARVALHO, The Weizmann Institute of Science
- Bertrand COLLIN, University of Burgundy
- Micha FRIDMAN, Tel Aviv University
- Ronen GABIZON, The Weizmann Institute of Science
- Klara GRANTZ SASKOVA, Institute of Organic Chemistry and Biochemistry of the CAS
- Ivan HIRSCH, Charles University
- Miroslav HAVRANEK, Apigenex
- Eva KUDOVA, Institute of Organic Chemistry and Biochemistry of the CAS
- Pavel MARTASEK, BIOCEV
- Petra MENOVA, UCT Prague
- Yifat MERBL, The Weizmann Institute of Science
- Andrej MICHALIK, De Clercq&partners
- Christoph RADEMACHER, University of Vienna
- Stanislav RADL, Zentiva
- Dominik REJMAN, Institute of Organic Chemistry and Biochemistry of the CAS
- Moran SHALEV-BENAMI, The Weizmann Institute of Science
- Frantisek STEPANEK, UCT Prague
- Remi TERRANOVA, Novartis
- Javier TERRIENTE, ZeClinics
- Stella VUKELIC, AbbVie
- Frank WAGNER, Charité – Universitätsmedizin Berlin